Company profile
MEDIdesign - MEDIdesign Biomedical Innovation & Insight
MEDIdesign Biomedical Innovation & Insight
Financial period: 1 Jul 2023 to 30 Jun 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQ1NTY5MjgzMGFkaXF6a2N4
Published 19 Feb 2025 02:37
CS01 | Transaction MzQ1NTY4NzAyNWFkaXF6a2N4
Published 19 Feb 2025 01:48
Company registered at Companies House
1 Jun 2020 to 31 Mar 2021
no public description
1 Mar 2019 to 31 May 2021
"An urgent need for radical change in allergy diagnostics is illustrated by: 1. Rapid growth in number of allergy sufferers e.g. incidence of food allergy in UK children doubled in 10 years, 44% of UK adults now have an allergy (_Mintel, 2010)_ 2. Lengthening waiting times for allergy testing (commonly over 2 years) 3. The EU's annual indirect avoidable c...
1 Feb 2018 to 31 Oct 2018
Feasibility study into innovative technology and related processes for allergy diagnostics, leading to earlier diagnosis, incorporating the design of systems for early identification and targeted testing of 'at risk' groups, and supporting implementation of effective allergy prevention strategies.
